OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effect of canagliflozin on N-terminal pro-brain natriuretic peptide in patients with type 2 diabetes and chronic heart failure according to baseline use of glucose-lowering agents
Atsushi Tanaka, Shigeru Toyoda, Takumi Imai, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 9
Atsushi Tanaka, Shigeru Toyoda, Takumi Imai, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 9
Showing 9 citing articles:
Canagliflozin reduces chemoresistance in hepatocellular carcinoma through PKM2-c-Myc complex-mediated glutamine starvation
Yuan Zeng, Haoran Jiang, Xiangting Zhang, et al.
Free Radical Biology and Medicine (2023) Vol. 208, pp. 571-586
Closed Access | Times Cited: 19
Yuan Zeng, Haoran Jiang, Xiangting Zhang, et al.
Free Radical Biology and Medicine (2023) Vol. 208, pp. 571-586
Closed Access | Times Cited: 19
The role of sodium-glucose co-transporter (SGLT)-2 inhibitors in heart failure management and implications for the kidneys
Eirini Lioudaki, Jennifer Joslin, Eirini Trachanatzi, et al.
Reviews in Cardiovascular Medicine (2022) Vol. 23, Iss. 3
Open Access | Times Cited: 4
Eirini Lioudaki, Jennifer Joslin, Eirini Trachanatzi, et al.
Reviews in Cardiovascular Medicine (2022) Vol. 23, Iss. 3
Open Access | Times Cited: 4
Effects of SGLT2 inhibitors on parameters of renal venous congestion in intrarenal Doppler ultrasonography
Manuel Wallbach, Jamil Ajrab, Bilgin Bayram, et al.
Clinical Kidney Journal (2024) Vol. 17, Iss. 9
Open Access
Manuel Wallbach, Jamil Ajrab, Bilgin Bayram, et al.
Clinical Kidney Journal (2024) Vol. 17, Iss. 9
Open Access
Association between serum insulin levels and heart failure-related parameters in patients with type 2 diabetes and heart failure treated with canagliflozin: a post-hoc analysis of the randomized CANDLE trial
Atsushi Tanaka, Takumi Imai, Michio Shimabukuro, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Atsushi Tanaka, Takumi Imai, Michio Shimabukuro, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Effects of sodium-glucose cotransporter-2 inhibitors on nutritional status in heart failure with reduced ejection fraction
Kadem Arslan, Emre Yılmaz, Ercan Aydın
Revista da Associação Médica Brasileira (2022) Vol. 68, Iss. 11, pp. 1576-1581
Open Access | Times Cited: 2
Kadem Arslan, Emre Yılmaz, Ercan Aydın
Revista da Associação Médica Brasileira (2022) Vol. 68, Iss. 11, pp. 1576-1581
Open Access | Times Cited: 2
Comparing the Effects of Canagliflozin vs. Glimepiride by Body Mass Index in Patients with Type 2 Diabetes and Chronic Heart Failure: A Subanalysis of the CANDLE Trial
Akira Sezai, Atsushi Tanaka, Takumi Imai, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1656-1656
Open Access | Times Cited: 1
Akira Sezai, Atsushi Tanaka, Takumi Imai, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1656-1656
Open Access | Times Cited: 1
Effect of canagliflozin on white blood cell counts in patients with type 2 diabetes and heart failure: A subanalysis of the randomizedCANDLE trial
Atsushi Tanaka, Takumi Imai, Michio Shimabukuro, et al.
Journal of Diabetes Investigation (2022) Vol. 13, Iss. 12, pp. 1990-1999
Open Access | Times Cited: 1
Atsushi Tanaka, Takumi Imai, Michio Shimabukuro, et al.
Journal of Diabetes Investigation (2022) Vol. 13, Iss. 12, pp. 1990-1999
Open Access | Times Cited: 1
Changes in Cardiovascular and Renal Biomarkers Associated with SGLT2 Inhibitors Treatment in Patients with Type 2 Diabetes Mellitus
Μelpomeni Peppa, Aspasia Manta, Ioanna Mavroeidi, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2526-2526
Open Access
Μelpomeni Peppa, Aspasia Manta, Ioanna Mavroeidi, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2526-2526
Open Access
The Metabolic Model of Heart Failure; the Role of Sodium-Glucose Co-transporter 2(SGLT2) Inhibition
Mohammed Shaban, Franklin Sosa, Miguel A Rodriguez Guerra, et al.
Medical Research Archives (2022) Vol. 10, Iss. 6
Open Access
Mohammed Shaban, Franklin Sosa, Miguel A Rodriguez Guerra, et al.
Medical Research Archives (2022) Vol. 10, Iss. 6
Open Access
